Evidence map›Paper›PMID 36005577›Full record

ArticleMetabolites2022

Human Hepatocyte 4-Acetoxy-

Sara Malaca, Marilyn A Huestis, Leonardo Lattanzio, Luigi T Marsella, Adriano Tagliabracci, Jeremy Carlier, Francesco P Busardò

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Metabolites, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Synthesis and structure of 4-hy-droxy-Acta crystallographica. Section E, Crystallographic communications · 2023
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Sara MalacaUnit of Forensic Toxicology, Section of Legal Medicine, Department of Excellence of Biomedical Sciences and Public Health, Marche Polytechnic University, Via Tronto 10/a, 60126 Ancona, Italy.
Marilyn A HuestisInstitute of Emerging Health Professions, Thomas Jefferson University, Philadelphia, PA 19107, USA.ORCID 0000-0003-2137-4645
Leonardo LattanzioForensic Medicine, Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy.
Luigi T MarsellaForensic Medicine, Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy.
Adriano TagliabracciUnit of Forensic Toxicology, Section of Legal Medicine, Department of Excellence of Biomedical Sciences and Public Health, Marche Polytechnic University, Via Tronto 10/a, 60126 Ancona, Italy.ORCID 0000-0002-4434-0475
Jeremy CarlierUnit of Forensic Toxicology, Section of Legal Medicine, Department of Excellence of Biomedical Sciences and Public Health, Marche Polytechnic University, Via Tronto 10/a, 60126 Ancona, Italy.ORCID 0000-0003-3332-9518
Francesco P BusardòUnit of Forensic Toxicology, Section of Legal Medicine, Department of Excellence of Biomedical Sciences and Public Health, Marche Polytechnic University, Via Tronto 10/a, 60126 Ancona, Italy.
Marche Polytechnic University · ITUniversity of Rome Tor Vergata · ITThomas Jefferson University · US

Funding

Department for Antidrug Policies, Italy NA
6 · The paper itself

Abstract

Tryptamine intoxications and fatalities are increasing, although these novel psychoactive substances (NPS) are not controlled in most countries. There are few data on the metabolic pathways and enzymes involved in tryptamine biotransformation. 4-acetoxy-

Indexed as

4-AcO-DiPTdata mininghepatocyte metabolismin silico predictionliquid chromatography–high-resolution tandem mass spectrometry (LC-HRMS/MS)tryptamine

Identifiers

PMID36005577
PMCPMC9413566
OpenAlexW4288425119

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.